Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations

被引：99
|
作者：
Ahn, Inhye E. [1 ]
Tian, Xin [1 ]
Wiestner, Adrian [1 ]
机构：
[1] NHLBI, Bldg 10, Bethesda, MD 20892 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 383卷 / 05期
关键词：
CLL;
D O I：
10.1056/NEJMc2005943
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with chronic lymphocytic leukemia with chromosome 17 abnormalities have a worse prognosis than those without such alterations. In this phase 2 study, patients who received continuous ibrutinib had a durable response that continued after 6.5 years in some patients.
引用
收藏
页码：498 / 500
页数：3
相关论文
共 50 条
  • [41] Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia
    Thornton, PD
    Gruszka-Westwood, AM
    Hamoudi, RA
    Atkinson, S
    Kaczmarek, P
    Morilla, RM
    Hilditch, BL
    A'Hern, R
    Matutes, E
    Catovsky, D
    HEMATOLOGY JOURNAL, 2004, 5 (01) : 47 - 54
  • [42] Pathogenic germline variants of TP53 gene are rare in patients with chronic lymphocytic leukemia
    Pavlova, Sarka
    Malcikova, Jitka
    Gombikova, Johana
    Smardova, Jana
    Plevova, Karla
    Kotaskova, Jana
    Dvorackova, Barbara
    Vonkova, Barbara Kunt
    Zavacka, Kristyna
    Navrkalova, Veronika
    Trizuljak, Jakub
    Doubek, Michael
    Pospisilova, Sarka
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 542 - 543
  • [43] Significance of TP53 Codon 72 in a Cohort of Egyptian Chronic Lymphocytic Leukemia Patients
    Saleh, Layla
    Elnagar, Fatma El-Zahraa
    Emarah, Ziad
    Eissa, Noha
    Abdel-Ghaffar, Hasan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S282 - S283
  • [44] Chronic lymphocytic Leukemia and deletion of the TP53 gene: Case report and literature review
    Carolina Ucroz-Benavides, Andrea
    Mauricio Galvez-Cardenas, Kenny
    Cecilia Ramirez-Gaviria, Gloria
    Gomez-Lopere, Natalia
    Vasquez-Palacio, Gonzalo
    IATREIA, 2021, 34 (04) : 370 - 374
  • [45] Selection and clinical relevance of monoallelic and biallelic TP53 defects in chronic lymphocytic leukemia
    Malcikova, J.
    Trbusek, M.
    Smardova, J.
    Rocnova, L.
    Tichy, B.
    Kuglik, P.
    Brychtova, Y.
    Doubek, M.
    Mayer, J.
    Pospisilova, S.
    EJC SUPPLEMENTS, 2010, 8 (05): : 42 - 42
  • [46] TP53 Mutation Analysis in Clinical Practice: Lessons From Chronic Lymphocytic Leukemia
    Malcikova, Jitka
    Pavlova, Sarka
    Kozubik, Katerina Stano
    Pospisilova, Sarka
    HUMAN MUTATION, 2014, 35 (06) : 663 - 671
  • [47] Diagnostic techniques and therapeutic challenges in patients with TP53 dysfunctional chronic lymphocytic leukemia
    Best, Giles
    Thompson, Philip
    Tam, Constantine S.
    LEUKEMIA & LYMPHOMA, 2012, 53 (11) : 2105 - 2115
  • [48] TP53 GENE MUTATION ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA BY NANOPORE MINION SEQUENCING
    Minervini, C. F.
    Cumbo, C.
    Orsini, P.
    Anelli, L.
    Zagaria, A.
    Minervini, A.
    Casieri, P.
    Coccaro, N.
    Tota, G.
    Impera, L.
    Giordano, A.
    Brunetti, C.
    Specchia, G.
    Albano, F.
    HAEMATOLOGICA, 2016, 101 : S109 - S109
  • [49] Therapeutic Options for Patients with TP53 Deficient Chronic Lymphocytic Leukemia: Narrative Review
    Stefaniuk, Paulina
    Onyszczuk, Julia
    Szymczyk, Agnieszka
    Podhorecka, Monika
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 1459 - 1476
  • [50] HIGH-THROUGHPUT SEQUENCING FOR THE IDENTIFICATION OF TP53 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Barbieri, M.
    Favoino, C.
    Colombo, M.
    Manzoni, M.
    Cutrona, G.
    Matis, S.
    Fabris, S.
    Gentile, M.
    Recchia, A.
    Bossio, S.
    De Stefano, L.
    Fama, A.
    Vincoli, D.
    Musolino, C.
    Molica, S.
    Cortelezzi, A.
    Di Raimondo, F.
    Morabito, F.
    Ferrarini, M.
    Neri, A.
    Lionetti, M.
    HAEMATOLOGICA, 2016, 101 : S26 - S26
12345